Results 91 to 100 of about 4,456,525 (155)

Classification of Intensity-Modulated Proton Therapy Plans [PDF]

, 2018
Title: Classification of IMPT Plans Purpose: Create a method to aid physicists and dosimetrists in the classification of Intensity Modulated Proton Therapy treatment plans. Method: A Python program was developed to read structure sets and dose grids from
Liu, Alice
core  

Impact of anatomical changes on simulated proton arc therapy and intensity-modulated proton therapy for lung cancer. [PDF]

J Appl Clin Med Phys
Chen W, Yang F, Zeng F, Guo H, Xu Y, Zhang T, Wu J, Zhang D, Liu G, Ding X, Wang X.   +10 more
europepmc   +1 more source

Proton arc therapy reduces the dose delivered to circulating blood compared to intensity-modulated proton therapy for head-and-neck cancer. [PDF]

J Appl Clin Med Phys
Tattenberg S, Liu P, Cong X, Hoehr C, Ding X.   +4 more
europepmc   +1 more source

Comparison of intensity-modulated proton therapy (IMPT) and intensity-modulated radiotherapy (IMRT) for oropharyngeal cancer: efficacy and toxicity differ by outcome measure. [PDF]

ESMO Open
You J, You J, Xu B, Zhou Z.
europepmc   +1 more source

Feasibility of reduced setup uncertainty in intensity-modulated proton therapy for mediastinal lymphoma. [PDF]

Phys Imaging Radiat Oncol
Pisciotta P, Hengeveld A, Korevaar EW, Visser S, Wagenaar D, Klinker P, Maduro JH, Langendijk JA, Niezink AG, Both S.   +9 more
europepmc   +1 more source

Quantitative evaluation of taste dysfunction using electrogustometry in patients with head and neck cancer undergoing intensity-modulated radiation therapy and intensity-modulated proton therapy. [PDF]

J Radiat Res
Shima T, Yasuda K, Suzuka M, Yamano S, Takeuchi A, Iwai N, Kanno Y, Dekura Y, Minatogawa H, Fujita Y, Miyazaki T, Koizumi F, Takahashi S, Aoyama H, Minowa K.   +14 more
europepmc   +1 more source

Comparison of in-field secondary cancer risk based on therapeutic proton dose between proton arc therapy and intensity-modulated proton therapy in lung cancer patients. [PDF]

J Appl Clin Med Phys
Xu Y, Chen W, Wu J, Guo H, Zeng F, Zhang T, Yang F, Huang X, Zhang D, Wang X.   +9 more
europepmc   +1 more source

Clinical implementation of intensity modulated proton therapy in breath-hold for mediastinal lymphoma patients using surface monitoring and nasal high-flow therapy. [PDF]

Phys Imaging Radiat Oncol
Vilches-Freixas G, van der Klugt K, Canters R, Kneepkens E, Vereijken F, Cobben M, van den Bosch M, Lubken I, van Engelen A, Stultiens C, Velders M, Cartechini G, Unipan M, Berbée M, Ta B.   +14 more
europepmc   +1 more source

Improved organs-of-interest dose reduction potential with intensity modulated proton therapy and breath-hold in mediastinal lymphoma. [PDF]

Phys Imaging Radiat Oncol
Ta BDP, Canters RAM, van der Klugt K, Vilches-Freixas G, Kneepkens E, Vereijken F, Cobben M, van den Bosch M, Lubken I, Stultiens C, Velders M, Verstappen T, Tholen G, Niezink AGH, De Ruysscher DKM, Berbée M.   +15 more
europepmc   +1 more source

Biologically Effective Dose-Optimized Multi-Intensity-Modulated Proton Therapy: A Biologically Comparable Alternative to Proton Arc Therapy. [PDF]

Int J Part Ther
Shinde N, Zhu Y, Wang W, Li W, Lin Y, Gan GN, Lominska C, Rotondo R, Chen RC, Gao H.   +9 more
europepmc   +1 more source